USPTO serial 76331795
ZLB
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- LEIPZIG, MARC J
- Law office
- INTENT TO USE UNIT
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ZLB?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
BERN 22, CH
CH-3000 Bern 22, CH
CH-3000 Bern 22, CH
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
JOHN R. GARBER
JOHN R GARBER COOPER & DUNHAM LLP1185 AVE OF THE AMERICASNEW YORK, NY 10036UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | CHEMICAL REAGENTS FOR INDUSTRIAL, SCIENTIFIC AND MEDICAL RESEARCH USE; SERA FOR SCIENTIFIC, INDUSTRIAL AND MEDICAL RESEARCH, NAMELY, THE PRODUCTION OF PHARMACEUTICALS, VACCINES, MONOCLONAL ANTIBODIES AND RECOMBINANT PROTEINS; SERA ALTERNATIVES IN THE NATURE OF BIOCHEMICALS, NAMELY, PRECURSORS, MONOCLONAL ANTIBODIES, POLYPEPTIDES FOR USE IN CELL CULTURE SCIENTIFIC RESEARCH; BIOLOGICALS, NAMELY PRECURSORS, MONOCLONAL ANTIBODIES, POLYPEPTIDES DERIVED FROM BACTERIA VIRUSES AND ANIMALS, FOR USE AS DILUENTS IN CELL CULTURE SCIENTIFIC RESEARCH APPLICATIONS; SERA PRODUCTS IN THE NATURE OF BIOLOGICALS, NAMELY, PRECURSORS, MONOCLONAL ANTIBODIES, POLYPEPTIDES, DERIVED FROM BACTERIAL VIRUSES AND ANIMALS, FOR USE AS DILUENTS IN CELL CULTURE SCIENTIFIC RESEARCH APPLICATIONS; DIAGNOSTIC CHEMICAL AND BIOLOGICAL REAGENTS FOR SCIENTIFIC, INDUSTRIAL OR MEDICAL RESEARCH USE; BIOCHEMICALS, NAMELY, MONOCLONAL ANTIBODIES USED FOR IN VITRO SCIENTIFIC OR RESEARCH USE; CELL CULTURE MEDIA FOR SCIENTIFIC, LABORATORY OR MEDICAL RESEARCH, NAMELY, CELL MEDIA FOR USE IN THE PRODUCTION OF PHARMACEUTICALS, VACCINES, MONOCLONAL ANTIBODIES AND RECOMBINANT PROTEINS | ACTIVE | — |
| 005 | DIAGNOSTIC REAGENTS FOR IN VITRO USE IN BIOCHEMISTRY, CLINICAL CHEMISTRY AND MICROBIOLOGY; MEDIA FOR BACTERIOLOGICAL CULTURES, NAMELY, CHEMICALLY DEFINED MEDIA SUPPLEMENTS FOR THE GROWTH OF BACTERIA, VIRAL OR ANIMAL CELLS IN CULTURE; PHARMACEUTICAL PREPARATIONS DERIVED FROM PLASMA AND RECOMBINANT DNA TECHNOLOGY FOR THE PREVENTION AND/OR TREATMENT OF BLOOD DISORDERS; BLOOD PRODUCTS, NAMELY, PLASMA VOLUME EXPANDERS, HUMAN ALBUMIN, BLOOD CLOTTING FACTORS AND IMMUNOGLOBULINS FOR MEDICAL AND CLINICAL USE; TEST KITS CONSISTING PRIMARILY OF CLINICAL DIAGNOSTIC REAGENTS AND BLOOD PLASMA; MEDIA FOR BACTERIOLOGICAL CULTURES FOR MEDICAL PURPOSES | ACTIVE | — |
| 010 | DEVICES AND INSTRUMENTS FOR THE ADMINISTRATION AND DELIVERY OF PHARMACEUTICAL PREPARATIONS FOR USE IN THE HUMAN IMMUNE DISORDERS AND HUMAN IMMUNE SYSTEM | ACTIVE | — |
| 040 | FRACTIONATION OF PLASMA TO OBTAIN INTERMEDIATE PRODUCTS FOR THE MANUFACTURE OF DIFFERENT PHARMACEUTICAL PRODUCTS; TREATMENT OF HUMAN BIOLOGICAL PRODUCTS, NAMELY, CUSTOM MANUFACTURING AND FRACTIONATION OF BLOOD AND PLASMA | ACTIVE | — |
| 042 | HEALTH AND HYGIENE CARE, NAMELY, HEALTHCARE SERVICES; SCIENTIFIC AND INDUSTRIAL RESEARCH | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ZLB BEHRING AG
- Other trademarks owned by ZLB Bioplasma AG
- Other trademarks owned by ZLB Bioplasma AG
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named ZLB
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 8, 2005 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 6, 2005 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Aug 31, 2004 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Aug 18, 2004 | EXT1 | SOU EXTENSION 1 FILED | — |
| Aug 18, 2004 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 14, 2004 | PAPER RECEIVED | — | |
| Mar 2, 2004 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 9, 2003 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 19, 2003 | NPUB | NOTICE OF PUBLICATION | — |
| Oct 8, 2003 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 8, 2003 | CFIT | CASE FILE IN TICRS | — |
| Aug 14, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 14, 2003 | PAPER RECEIVED | — | |
| May 19, 2003 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 8, 2003 | PETG | PETITION TO REVIVE-GRANTED | — |
| Apr 30, 2003 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Apr 7, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 7, 2003 | PETR | PETITION TO REVIVE-RECEIVED | — |
| Apr 7, 2003 | PAPER RECEIVED | — | |
| Apr 3, 2003 | PAPER RECEIVED | — | |
| Sep 5, 2002 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 5, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 5, 2002 | PAPER RECEIVED | — | |
| Feb 4, 2002 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 28, 2002 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 25, 2002 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 11, 2002 | DOCK | ASSIGNED TO EXAMINER | — |